• German nuclear policy skirts a taboo

    Germany's nuclear power policy of keeping old reactors open longer to bridge the gap to greener energy may also leave the door open to eventually break a major electoral taboo -- new atomic power plants.
  • Brakes on for buoyant European auto shares

    European auto stocks have powered ahead this year thanks to the performance of sector heavyweight DaimlerChrysler and talk of industry restructuring, but the brakes are set to come on.
  • Hedge fund GLG eyes U.S. listing with reverse deal

    GLG Partners, one of Europe's largest hedge fund firms, has lined up a U.S. stock market listing to help it expand and hire top managers, using a reverse acquisition with a shell company that values it at $3.4 billion.
  • Germany's Merck to buy Serono for $13.3 bln

    Germany drugmaker Merck KGaA unveiled a surprise 16.6-billion-Swiss franc ($13.3 billion) deal on Thursday to buy Swiss biotech firm Serono, creating a new force in European pharmaceuticals.
  • Merck to buy Serono for $13.3 billion

    German drugmaker Merck on Thursday unveiled a surprise 16.6 billion Swiss franc (7 billion pound) deal to buy Swiss biotech firm Serono
  • European stocks gain as oil dips, BP climbs

    European shares rebounded slightly on Friday, regaining some ground after losses suffered this week on growth and inflation worries, as oil slipped to a five month low.